{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:43:34Z","timestamp":1792478614003,"version":"4.5.0"},"reference-count":53,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15878","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:01:27Z","timestamp":1789992087000},"page":"1-17","source":"Crossref","is-referenced-by-count":0,"title":["Pan\u2011cancer prognostic value of TGFBR1: Bioinformatics and experimental validation with a focus on gastric cancer"],"prefix":"10.3892","volume":"32","author":[{"given":"Xia","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Zibo Central Hospital, Zibo, Shandong 255036, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lufan","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Pathogenic Biology, School of Basic Medicine, Qingdao University, Qingdao, Shandong 266071, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Pathogenic Biology, School of Basic Medicine, Qingdao University, Qingdao, Shandong 266071, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengwen","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Pathogenic Biology, School of Basic Medicine, Qingdao University, Qingdao, Shandong 266071, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Zibo Central Hospital, Zibo, Shandong 255036, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxi","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Zibo Central Hospital, Zibo, Shandong 255036, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinli","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Zibo Central Hospital, Zibo, Shandong 255036, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"key20261020093255_b1-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The cancer genome atlas Pan-Cancer analysis project","volume":"45","author":"Weinstein","year":"2013","journal-title":"Nat Genet"},{"key":"key20261020093255_b2-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s00262-020-02739-w","article-title":"A pan-cancer analysis of the human tumor coagulome and its link to the tumor immune microenvironment","volume":"70","author":"Saidak","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"key20261020093255_b3-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.semcancer.2017.08.012","article-title":"Phosphatidylserine: A cancer cell targeting biomarker","volume":"52","author":"Sharma","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"key20261020093255_b4-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"831542","DOI":"10.3389\/fimmu.2022.831542","article-title":"A Pan-cancer analysis reveals CLEC5A as a biomarker for cancer immunity and prognosis","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol"},{"key":"key20261020093255_b5-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.cellsig.2011.04.004","article-title":"Homomeric and heteromeric complexes among TGF-\u03b2 and BMP receptors and their roles in signaling","volume":"23","author":"Ehrlich","year":"2011","journal-title":"Cell Signal"},{"key":"key20261020093255_b6-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1126\/science.1071809","article-title":"Signal transduction by the TGF-beta superfamily","volume":"296","author":"Attisano","year":"2002","journal-title":"Science"},{"key":"key20261020093255_b7-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/emboj\/16.13.3912","article-title":"A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity","volume":"16","author":"Feng","year":"1997","journal-title":"EMBO J"},{"key":"key20261020093255_b8-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0955-0674(96)80058-5","article-title":"Signaling via hetero-oligomeric complexes of type I and type II serine\/threonine kinase receptors","volume":"8","author":"ten Dijke","year":"1996","journal-title":"Curr Opin Cell Biol"},{"key":"key20261020093255_b9-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"a022061","DOI":"10.1101\/cshperspect.a022061","article-title":"TGF-beta Signaling from Receptors to Smads","volume":"8","author":"Hata","year":"2016","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"key20261020093255_b10-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.devcel.2009.02.012","article-title":"Tgf-beta superfamily signaling in embryonic development and homeostasis","volume":"16","author":"Wu","year":"2009","journal-title":"Dev Cell"},{"key":"key20261020093255_b11-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.cellsig.2018.09.002","article-title":"TGF-\u03b2 receptors: In and beyond TGF-\u03b2 signaling","volume":"52","author":"Vander Ark","year":"2018","journal-title":"Cell Signal"},{"key":"key20261020093255_b12-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10911-011-9216-2","article-title":"TGFBR1 signaling and breast cancer","volume":"16","author":"Moore-Smith","year":"2011","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"key20261020093255_b13-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1158\/0008-5472.CAN-07-5424","article-title":"TGFBR1*6A enhances the migration and invasion of MCF-7 breast cancer cells through RhoA activation","volume":"68","author":"Rosman","year":"2008","journal-title":"Cancer Res"},{"key":"key20261020093255_b14-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1002\/cncr.26018","article-title":"Genetic variation in the transforming growth factor-\u03b2 signaling pathway and survival after diagnosis with colon and rectal cancer","volume":"117","author":"Slattery","year":"2011","journal-title":"Cancer"},{"key":"key20261020093255_b15-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12935-018-0682-0","article-title":"Polymorphisms of TGFBR1, TLR4 are associated with prognosis of gastric cancer in a Chinese population","volume":"18","author":"He","year":"2018","journal-title":"Cancer Cell Int"},{"key":"key20261020093255_b16-ol-32-5-15878","first-page":"211","article-title":"Transforming growth factor beta receptor 1 polyalanine polymorphism and exon 5 mutation analysis in breast and ovarian cancer","volume":"11","author":"Baxter","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20261020093255_b17-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1038\/sj.onc.1210046","article-title":"ALK5 promotes tumor angiogenesis by upregulating matrix metalloproteinase-9 in tumor cells","volume":"26","author":"Safina","year":"2007","journal-title":"Oncogene"},{"key":"key20261020093255_b18-ol-32-5-15878","first-page":"300","article-title":"TGFBR1 and cancer susceptibility","volume":"125","author":"Pasche","year":"2014","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"key20261020093255_b19-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3390\/cancers10080260","article-title":"LY2157299 monohydrate, a TGF-\u03b2R1 inhibitor, suppresses tumor growth and ascites development in ovarian cancer","volume":"10","author":"Zhang","year":"2018","journal-title":"Cancers (Basel)"},{"key":"key20261020093255_b20-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1007\/s10637-019-00835-y","article-title":"Pharmacokinetic characteristics of vactosertib, a new activin receptor-like kinase 5 inhibitor, in patients with advanced solid tumors in a first-in-human phase 1 study","volume":"38","author":"Jung","year":"2020","journal-title":"Invest New Drugs"},{"key":"key20261020093255_b21-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cels.2018.08.010","article-title":"A pan-cancer analysis reveals high-frequency genetic alterations in mediators of signaling by the TGF-\u03b2 superfamily","volume":"7","author":"Korkut","year":"2018","journal-title":"Cell Syst"},{"key":"key20261020093255_b22-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"1438161","DOI":"10.3389\/fphar.2024.1438161","article-title":"Isoliensinine suppressed gastric cancer cell proliferation and migration by targeting TGFBR1 to regulate TGF-\u03b2-smad signaling pathways","volume":"15","author":"Hu","year":"2024","journal-title":"Front Pharmacol"},{"key":"key20261020093255_b23-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"11250","DOI":"10.3390\/ijms262311250","article-title":"TGF-\u03b2 receptor inhibitor SB431542 enhanced the sensitivity of gastric cancer to 5-fluorouracil: New combined targeted therapy","volume":"26","author":"Bonomo","year":"2025","journal-title":"Int J Mol Sci"},{"key":"key20261020093255_b24-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"e1000676","DOI":"10.1371\/journal.pgen.1000676","article-title":"Oncogenic pathway combinations predict clinical prognosis in gastric cancer","volume":"5","author":"Ooi","year":"2009","journal-title":"PLoS Genet"},{"key":"key20261020093255_b25-ol-32-5-15878","article-title":"A Package for Survival Analysis in R. R package version 3.8\u20133","author":"Therneau"},{"key":"key20261020093255_b26-ol-32-5-15878","article-title":"Survminer: Drawing Survival Curves using \u2018ggplot2\u2019","author":"Kassambara","journal-title":"R package version 0.5.1."},{"key":"key20261020093255_b27-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"key20261020093255_b28-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: Efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"key":"key20261020093255_b29-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"key20261020093255_b30-ol-32-5-15878","doi-asserted-by":"publisher","DOI":"10.1200\/PO.17.00073","article-title":"Landscape of microsatellite instability across 39 cancer types","author":"Bonneville","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"key20261020093255_b31-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"key20261020093255_b32-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat Protoc"},{"key":"key20261020093255_b33-ol-32-5-15878","first-page":"100141","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"key20261020093255_b34-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"key20261020093255_b35-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nmeth.3252","article-title":"Orchestrating high-throughput genomic analysis with Bioconductor","volume":"12","author":"Huber","year":"2015","journal-title":"Nat Methods"},{"key":"key20261020093255_b36-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41568-022-00535-5","article-title":"Targeting DNA damage response pathways in cancer","volume":"23","author":"Groelly","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"key20261020093255_b37-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.gpb.2023.02.004","article-title":"Patient assessment and therapy planning based on homologous recombination repair deficiency","volume":"21","author":"Li","year":"2023","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"key20261020093255_b38-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"975","DOI":"10.4143\/crt.2024.154","article-title":"Recent advances in genomic approaches for the detection of homologous recombination deficiency","volume":"56","author":"Kim","year":"2024","journal-title":"Cancer Res Treat"},{"key":"key20261020093255_b39-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41698-022-00339-8","article-title":"Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancer","volume":"6","author":"Perez-Villatoro","year":"2022","journal-title":"NPJ Precis Oncol"},{"key":"key20261020093255_b40-ol-32-5-15878","first-page":"101003","article-title":"Trends of gastric cancer burdens attributable to risk factors in China from 2000 to 2050","volume":"44","author":"He","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"key20261020093255_b41-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cgh.2019.07.045","article-title":"Burden of gastric cancer","volume":"18","author":"Thrift","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20261020093255_b42-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/cas.13478","article-title":"Solute carrier family 35 member F2 is indispensable for papillary thyroid carcinoma progression through activation of transforming growth factor-\u03b2 type I receptor\/apoptosis signal-regulating kinase 1\/mitogen-activated protein kinase signaling axis","volume":"109","author":"He","year":"2018","journal-title":"Cancer Sci"},{"key":"key20261020093255_b43-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.2147\/IJGM.S353879","article-title":"Comprehensive characterization of transforming growth factor beta receptor 1 in stomach adenocarcinoma identifies a prognostic signature for predicting clinical outcomes and immune infiltrates","volume":"15","author":"He","year":"2022","journal-title":"Int J Gen Med"},{"key":"key20261020093255_b44-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","article-title":"TGF\u03b2 biology in cancer progression and immunotherapy","volume":"18","author":"Derynck","year":"2021","journal-title":"Nature reviews Clin Oncol"},{"key":"key20261020093255_b45-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","article-title":"TGF-\u03b2 signaling in health, disease, and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"key20261020093255_b46-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.canlet.2019.11.009","article-title":"Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy","volume":"470","author":"Lei","year":"2020","journal-title":"Cancer Lett"},{"key":"key20261020093255_b47-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"e70601","DOI":"10.1002\/ctm2.70601","article-title":"Metabolic reprogramming of efferocytosis in the tumour microenvironment: From apoptotic-cell clearance to therapeutic targeting","volume":"16","author":"Yang","year":"2026","journal-title":"Clin Transl Med"},{"key":"key20261020093255_b48-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12943-022-01670-1","article-title":"Targeting the tumor stroma for cancer therapy","volume":"21","author":"Xu","year":"2022","journal-title":"Mol Cancer"},{"key":"key20261020093255_b49-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The tumor microenvironment innately modulates cancer progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res"},{"key":"key20261020093255_b50-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"key20261020093255_b51-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"6315","DOI":"10.1038\/s41467-020-19920-5","article-title":"TGF\u03b2-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts","volume":"11","author":"Grauel","year":"2020","journal-title":"Nat Commun"},{"key":"key20261020093255_b52-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41389-021-00302-5","article-title":"TGF-\u03b21-mediated transition of resident fibroblasts to cancer-associated fibroblasts promotes cancer metastasis in gastrointestinal stromal tumor","volume":"10","author":"Yoon","year":"2021","journal-title":"Oncogenesis"},{"key":"key20261020093255_b53-ol-32-5-15878","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s12094-020-02456-x","article-title":"MGMT-inhibitor in combination with TGF-\u03b2RI inhibitor or CDK 4\/6 inhibitor increases temozolomide sensitivity in temozolomide-resistant glioblastoma cells","volume":"23","author":"Das","year":"2021","journal-title":"Clin Transl Oncol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:33:02Z","timestamp":1792477982000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":53,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,9,21]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15878","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]}}}